Absci Partners With Bioinformatics Company M2GEN To Accelerate Drug Creation For Oncology
Absci Corporation (NASDAQ:ABSI), a generative AI drug creation company, and M2GEN, an oncology bioinformatics company with the most advanced lifetime-consented clinicogenomics data to accelerate discovery